![]() |
市场调查报告书
商品编码
1820396
内视镜设备市场规模、份额、趋势及预测(按类型、应用、最终用途和地区),2025 年至 2033 年Endoscopy Devices Market Size, Share, Trends and Forecast by Type, Application, End Use, and Region, 2025-2033 |
2024年,全球内视镜设备市场规模达500.1亿美元。展望未来, IMARC Group预测,到2033年,市场规模将达到859.3亿美元,2025-2033年期间的复合年增长率为5.58%。目前,北美占据内视镜设备市场的主导地位,2024年其市占率将超过38.6%。受微创手术在各个医疗领域的日益普及、胃肠道疾病和癌症发病率的上升(需要频繁进行内视镜检查以进行早期发现)以及技术的持续进步的推动,内视镜设备市场正在稳步增长。
全球内视镜设备市场的成长主要得益于微创手术技术的进步、胃肠道疾病和慢性疾病的日益流行以及老龄化人口对诊断和治疗程序的需求。此外,人们对早期疾病检测意识的不断提高以及高清成像系统和机器人辅助内视镜等技术创新也进一步推动了市场的成长。 2024年12月10日,美国食品药物管理局(FDA)授予EndoQuest Robotics公司一项关键性PARADIGM临床研究的临床试验豁免,以评估其新型腔内手术(ELS)系统在机器人内视镜黏膜下剥离术(ESD)中用于结直肠病变切除的安全性和性能。这项多中心试验将在美国顶尖医疗机构招募50名患者,旨在透过灵活的机器人技术改造微创手术,使手术不留疤痕。新兴经济体医疗支出的增加和医疗设施可近性的改善正在推动对内视镜设备的需求。此外,向门诊环境的转变和对具有成本效益的程序的偏好进一步支持了市场的成长。
美国是一个重要的区域市场,其主要驱动因素是肥胖、大肠癌和其他生活方式相关疾病的盛行率不断上升,这些疾病需要先进的诊断工具。优惠的报销政策和强大的医疗基础设施支持内视镜手术的广泛应用。此外,老年人口的不断增长,易患慢性疾病,需要频繁的诊断和治疗干预,进一步刺激了需求。此外,主要参与者正在进行的研发工作正在推出创新技术,例如一次性内视镜和人工智慧辅助成像。 2025年1月25日,波士顿科学公司(Boston Scientific)启动了其已获FDA批准的VersaVue一次性柔性膀胱镜的限量市场推广,旨在改善泌尿道疾病的诊断和治疗。这款紧凑便携的仪器具有高清成像、一次性无菌设计以最大限度地降低感染风险,并且无需对可重复使用的内视镜进行再处理和维护。波士顿科学公司将在美国独家经销VersaVue,旨在改善临床工作流程和病患照护。同时,对早期疾病检测的日益关注和向基于价值的护理模式的转变也刺激了美国各地内视镜设备市场的需求。
内视镜设备的技术进步
全球内视镜设备市场份额的成长是由外科手术和器官特异性癌症的成长所推动的。根据世界卫生组织 (WHO) 的数据,大肠直肠癌是全球第三大常见癌症,每年新增病例超过 190 万例,这推动了对高清成像和先进柔性内视镜的需求。高清影像、微创手术方式以及可视化能力更强的柔性内视镜等技术的进步,正在彻底改变诊断和治疗领域。这些发展使不同疾病的诊断或治疗更加准确、损伤更小,从而缩短了患者的康復时间并降低了医疗成本。此外,人工智慧和机器学习在内视镜中的应用提高了疾病识别的准确性和手术效率。因此,医生对先进内视镜技术的日益接受,正在推动内视镜设备市场的成长,并增加了对先进内视镜系统持续研发的需求。
胃肠道疾病和癌症发生率上升
胃肠道疾病和癌症的日益流行是推动内视镜设备需求的主要因素之一。需要广泛使用内视镜技术的患者,包括患有大肠癌、胃肠道出血和发炎性肠道疾病的患者,也可被视为典型的临床族群。 2020 年,IARC 报告全球新增癌症病例 1,930 万例。胃肠道癌症在确诊的癌症中占很大比例,而仅大肠癌每年就造成超过 935,000 人死亡。内视镜技术的早期诊断已显示出胃肠道癌症存活率的提高,存活率提高了 40%。除了技术进步之外,早期诊断(也有助于早期治疗)对于良好的患者预后至关重要,有助于培养增加内视镜使用的文化。此外,老龄人口的成长使这些疾病更容易感染,这也进一步推动了市场的成长。此外,人们越来越重视医疗保健和使用内视镜对患者进行定期监测,这增强了对内视镜设备的整体持续需求,因为它们对于克服全球胃肠道癌症和其他癌症日益增长的患病率至关重要。
内视镜在各个医疗领域的应用不断扩大
内视镜在各个医疗领域的应用推动了全球内视镜设备市场规模的成长。除了胃肠病学之外,内视镜在泌尿科、妇科、肺科和骨科手术等不同临床专业的广泛应用都需要内视镜检查。根据美国肺臟协会的数据,支气管镜检查在诊断肺部疾病(包括肺癌)的应用日益广泛,每年有 220 万人罹患肺癌。这些应用多种多样,迫使人们开发适合临床需求的专用内视镜工具。此外,内视镜在诊断和治疗各种身体系统疾病的应用日益广泛,也增加了对内视镜的需求。例如,妇科用于治疗子宫内膜异位症的腹腔镜手术和用于治疗肾结石的微创泌尿外科手术。内视镜应用的扩大加强了市场成长,同时也对某些医学分支领域新型专用内视镜工具的进步和发展产生了积极影响。
The global endoscopy devices market size was valued at USD 50.01 Billion in 2024. Looking forward, IMARC Group estimates the market to reach USD 85.93 Billion by 2033, exhibiting a CAGR of 5.58% during 2025-2033. North America currently dominates the endoscopy devices market share, holding a significant market share of over 38.6% in 2024. The market is experiencing steady growth driven by the growing adoption of minimally invasive surgeries across various medical fields, the rising prevalence of gastrointestinal diseases and cancer necessitating frequent endoscopic procedures for early detection, and continual technological advancements.
The global endoscopy devices market growth is primarily driven by advancements in minimally invasive surgical techniques, growing prevalence of gastrointestinal and chronic diseases, and an aging population requiring diagnostic and therapeutic procedures. Along with this, rising awareness of early disease detection and technological innovations, such as high-definition imaging systems and robot-assisted endoscopy, further propels market growth. On 10th December 2024, The FDA granted EndoQuest Robotics its Investigational Device Exemption for the company's pivotal PARADIGM clinical study to assess the safety and performance of its novel Endoluminal Surgical (ELS) System in robotic endoscopic submucosal dissection (ESD) for colorectal lesion removal. The multicenter trial will enroll 50 patients across top U.S. healthcare institutions in an effort to transform minimally invasive surgery through flexible robotic technology, allowing procedures without leaving scars. Rising healthcare expenditures and improved access to medical facilities in emerging economies are driving demand for endoscopy devices. Additionally, the shift to outpatient settings and the preference for cost-effective procedures further support market growth.
The United States stands out as a key regional market, primarily driven by the increasing prevalence of obesity, colorectal cancer, and other lifestyle-related disorders that require advanced diagnostic tools. Favorable reimbursement policies and strong healthcare infrastructure support widespread adoption of endoscopic procedures. In addition, the rising geriatric population, prone to chronic conditions requiring frequent diagnostic and therapeutic interventions, further fuels demand. Furthermore, ongoing research and development efforts by key players are introducing innovative technologies such as single-use endoscopes and AI-assisted imaging. On 25th January 2025, Boston Scientific initiated a limited market launch of its FDA-cleared VersaVue single-use flexible cystoscope, intended to improve diagnostics and treatments for urinary tract diseases. The compact, portable instrument features high-definition imaging, a single-use sterile design to minimize the risk of infection, and no requirement for reprocessing and maintenance of reusable scopes. Boston Scientific will exclusively distribute VersaVue in the United States, targeting improvements in clinical workflows and patient care. Concurrently, the growing focus on early disease detection and the shift toward value-based care models also stimulate endoscopy devices market demand across the United States.
Technological Advancements in Endoscopic Equipment
The global endoscopy devices market share is driven by the increase in surgical procedures and organ-specific cancers. According to the World Health Organization (WHO), colorectal cancer is the third most common cancer globally, with over 1.9 million cases annually, driving demand for high-definition imaging and advanced flexible endoscopes. Advancements in technology such as high-definition imaging, minimal access surgical modalities, and the advent of improved flexible endoscopes with better visualization capabilities are revolutionizing diagnostic and therapeutic aspects. These developments are making the diagnosis or treatment of different medical conditions more accurate and less damaging, which leads to shorter patient recovery times and lower healthcare costs. Moreover, the utilization of artificial intelligence and machine learning in endoscopy improves disease identification accuracy and procedure efficiency. Consequently, the growing acceptance of advanced endoscopy technologies among physicians is propelling endoscopy devices market growth and escalating the demand for ongoing research and development efforts for advanced endoscopy systems.
Rising Prevalence of Gastrointestinal Diseases and Cancer
The increasing prevalence of gastrointestinal diseases and cancer is one of the major factors driving the demand for endoscopy devices. Those with indications for a broad spectrum of endoscopic techniques including colorectal cancer, gastrointestinal hemorrhage, and inflammatory bowel diseases may also be regarded as exemplary clinical populations. In 2020, IARC reported new cases of 19.3 million cancer diagnoses around the globe. GI cancers constituted a great number of the cancers diagnosed, while colorectal cancer alone is responsible for over 935,000 deaths each year. With a survival increase of 40%, early diagnosis by endoscopic techniques has shown improvement in survival from GI cancers. Apart from technological advancements, early diagnosis which is also leading to early treatment of these diseases is crucial for good patient outcomes, thereby aiding the culture of increased endoscopic use. In addition, the increasing aged population, which is more susceptible to these diseases, further drives market growth. Moreover, the increasing emphasis on healthcare and regular monitoring of patients with endoscopes enhances the overall continued demand for endoscopic devices, as they are fundamental in overcoming the rising prevalence of GI and other cancers worldwide.
Expanding Applications of Endoscopy in Various Medical Fields
Applications of endoscopy in diversified medical fields drive the global endoscopy devices market size. In addition to gastroenterology, a wide range of applications within different clinical specialties including urology, gynecology, pulmonology, and orthopedic surgeries in various clinical setups necessitate endoscopy. According to the American Lung Association, bronchoscopy is being increasingly used in the diagnosis of pulmonary conditions including lung cancer that affect 2.2 million individuals each year. These applications are varied and are forcing the development of special endoscopic tools tailored to clinical needs. Along with this, the increasing application of endoscopy for various body system disorders in diagnosis and treatment is also contributing to their demand. Some examples are laparoscopic surgeries in gynecology for endometriosis and minimally invasive urological procedures for kidney stones. This expansion of the utilization of endoscopy strengthens market growth while positively influencing the advancement and development of new types of specialized endoscopic tools for certain branches of medicine.
Endoscopy visualization systems lead the market with around 41.5% of market share in 2024. This can be attributed to their importance in increasing the accuracy and precision of diagnostic and therapeutic procedures. These systems include high-definition cameras, video processors, and display monitors that enhance image quality and resolution which is critical for the accurate identification and subsequent treatment of medical conditions. In particular, the inclusion of 4K and 3D imaging technologies acts as one of the major endoscopy devices market trends that leads to improved visualization systems performance through a more advanced level of detail in internal organs and tissue investigation. In addition, the rising adoption rate of minimally invasive procedures that require excellent visualizing systems for better outcomes will drive the demand for these solutions. Meanwhile, the sustained advances in imaging technology and the higher burden of gastrointestinal diseases and cancer ensure that endoscopy visualization systems will remain a lucrative revenue pocket meeting the changing demands from healthcare providers around the globe for best patient care.
Gastrointestinal endoscopy leads the market with around 55.4% of market share in 2024 due to the escalating number of gastrointestinal diseases and disorders across the globe. This segment includes procedures such as colonoscopy, gastroscopy, and endoscopic retrograde cholangiopancreatography (ERCP) needed for accurate treatment of diseases including colorectal cancer, gastrointestinal bleeding, and inflammatory bowel disease. Along with this, the increasing awareness among patients to undergo diagnosis in the early stage and rising trend of preventive healthcare, are two key drivers facilitating the growth of gastrointestinal endoscopy. These procedures benefit from improved equipment and advanced technologies such as smoother imaging, and enhanced capabilities paired with the convenience of less invasive procedures. The segment is further experiencing market growth as prevalence in the geriatric population with gastrointestinal disorders has been increasing.
Hospitals and clinics lead the market with around 51.0% of market share in 2024. They provide a broad spectrum of diagnostic and therapeutic applications. These endoscopy centers have state-of-the-art endoscopy equipment and resources, so they are capable of delivering a full range of endoscopic procedures needed to diagnose and treat various disorders. Additionally, centers and clinics with specialist medical professionals provide access to research-backed treatments for a fraction of patients. In addition, the large number of patient flow and the urgency of receiving accurate diagnoses on time in these areas present a significant requirement for endoscopy devices. Endoscopy also becomes more enhanced as a whole with high-end technological improvements, helping hospitals and clinics hold the largest endoscopy devices market share. Moreover, the growing burden of chronic diseases and the growing demand for minimally invasive procedures accentuate the adoption of endoscopy devices by hospitals and clinics, solidifying their dominance in the endoscopy devices market.
In 2024, North America accounted for the largest market share of over 38.6%. North America has the highest market share in the market, driven by high per capita income and intense R&D activities that foster innovation for high-quality miniature endoscopes for diagnostic applications. Extra sales growth stems from the region using new diagnostic imaging, high-definition video, and robotics endoscopy technologies first. In addition to this, the rising incidence of lifestyle-related chronic disorders such as cancer and gastrointestinal disorders necessitates more endoscopy procedures. Accessibility to advanced endoscopy equipment opportunities is made easily progressively due to the high presence of top medical device manufacturers and their research and development activities. Along with this, government support and a favorable reimbursement climate are essential facilitators for advanced endoscopic services. Concurrently, the increasing burden of diseases has a positive impact on the endoscopy devices market, along with the growing awareness of early disease detection and preventive healthcare. Moreover, North America leads the way in the adoption of state-of-the-art endoscopy steering healthcare performances and patient outcomes across the globe which is creating a positive endoscopy devices market outlook.
United States Endoscopy Devices Market Analysis
In 2024, the US accounted for around 82.90% of the total North America endoscopy devices market. High expenditure on health, technological progress, and elevated gastrointestinal diseases prevails the U.S. endoscopy devices market. According to the Centers for Medicare & Medicaid Services, expenditures in the health care sector rose to USD 4.5 trillion in 2022 alone. Much funding has been placed for high-quality equipment such as endoscopy devices. Minimally invasive treatments have always gained a position among the world's aging populations. Further technologies such as an AI-powered endoscope are considered more accurate while making a diagnosis. Boston Scientific and Medtronic, for example, are significant players in the market, targeting hospitals and out-of-hospital facilities. The domestic production of devices stabilizes the supply chain and reduces import dependency. Federal initiatives that encourage early disease detection contribute further to demand stimulation. Increasing R&D investments in innovative products help U.S. manufacturers expand their business worldwide, further consolidating their position in the endoscopy devices market.
Europe Endoscopy Devices Market Analysis
The growth of the European endoscopy devices market is driven by rising healthcare investments, a growing incidence of chronic diseases, and early diagnostics. As per the European Commission, in 2022, Germany had allocated EUR 489 billion, which is approximately USD 522 billion, for healthcare purposes, including medical technologies like endoscopy devices. The demand for robotic-assisted endoscopy is rising in countries like the UK and France, driven by technological advancements and the growing preference for minimally invasive solutions. Furthermore, diagnostic endoscopy devices are also expected to be sought out with the increase in colorectal cancer screening programs that are reported by the European Society of Gastrointestinal Endoscopy. Olympus and Karl Storz are among the key players with the most recent technological advancements. Strict EU regulations ensure product quality and safety. Public healthcare systems collaborate with manufacturers to support R&D, thus making Europe the hub for innovation in endoscopy.
Asia Pacific Endoscopy Devices Market Analysis
Rapidly increasing healthcare spending, awareness of preventive health care, and the growth in the middle class are factors improving the Asia Pacific endoscopy devices market. As per the data provided by China's National Bureau of Statistics, health care expenditure in China stood at USD 1,268.603 billion during 2022, focusing more on advanced diagnostic tools such as endoscopy devices. India's National Health Mission focuses on early disease detection, and in its 2023-2024 budget, the Ministry of Health and Family Welfare has allocated USD 8 billion to healthcare. The outpatient endoscopic procedures in the region are rapidly increasing as these procedures are inexpensive and have very short recovery periods. Innovation in the sector is led by companies such as Fujifilm and Pentax Medical, while the R&D for next-generation endoscopic systems is being supported by initiatives such as Japan's AMED. The partnerships between global and local players enhance technology transfer, making Asia Pacific a key market for endoscopy devices.
Latin America Endoscopy Devices Market Analysis
Growth drivers for Latin America's endoscopy devices market include increasing budgets for healthcare and access to the same, besides a growing number of gastrointestinal diseases. ITA states that in 2022, Brazil spent around USD 161 billion on its healthcare budget. The investments under this budget in diagnostic technologies continue to grow, with public-private partnerships in places including Mexico and Chile working toward improving endoscopic diagnostic capabilities across more rural and less privileged areas. The growing medical tourism in Costa Rica and Colombia enhances the demand for advanced endoscopic devices for minimally invasive procedures. Companies such as Hoya Group are now expanding their operations in the region to cater to this growing demand. Government-sponsored training programs for healthcare professionals help improve the adoption of endoscopic techniques, thus further enhancing the market. Growing healthcare infrastructure in Latin America makes it an emerging player in the global endoscopy devices industry.
Middle East and Africa Endoscopy Devices Market Analysis
Increasing healthcare infrastructure investments along with the escalating prevalence of chronic diseases are currently driving the market for endoscopy devices in the Middle East and Africa. According to International Trade Administration, Saudi Arabia allotted USD 36.8 billion to healthcare during 2022, which targeted the modernization of hospitals as well as the diagnostics sector. In South Africa, there is a developing demand for diagnostic services through less invasive procedures among both public as well as private systems, which tend to prefer advanced endoscopy devices. Regional manufacturers, such as United Surgical, offer competitive, locally sensitive products. Emphasis on developing health care facilities by the government of the UAE under Vision 2030 along with diagnostic technology promotes the acceptance of endoscopic equipment. Awareness among individuals through tie-ups with global players creates more demand. In the Middle East and Africa, the advancement of health care and strategic investment have made the region a great place for endoscopic equipment.
The key players operating in the endoscopy devices market forecast are investing in R&D to find new technologies and update their products. Olympus Corporation, Karl Storz, and Stryker are focusing on these areas, with new imaging technologies, AI & machine learning solutions for better detection, and more flexible or adaptable endoscopes built. In addition, they pursue various primary strategies such as partnerships and global acquisitions to expand their product portfolio on a global level. Moreover, endoscopy devices companies are concentrating on manufacturing minimally invasive surgical tools, as the demand for this surgery is significantly increasing. Sustained training and education programs for healthcare professionals also bolster the utilization of advanced endoscopy devices in clinical applications.